Viewing Study NCT04721132


Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2025-12-28 @ 10:43 PM
Study NCT ID: NCT04721132
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-23
First Post: 2021-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module